Insider Spends US$258k Buying More Shares In Marten Transport

Potential Marten Transport, Ltd. (NASDAQ:MRTN) shareholders may wish to note that the Independent Director, Jerry Bauer, recently bought US$258k worth of stock, paying US$12.88 for each share. That's a very solid buy in our book, and increased their holding by a noteworthy 13%.
We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.
In fact, the recent purchase by Jerry Bauer was the biggest purchase of Marten Transport shares made by an insider individual in the last twelve months, according to our records. That means that even when the share price was higher than US$12.84 (the recent price), an insider wanted to purchase shares. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. We always take careful note of the price insiders pay when purchasing shares. As a general rule, we feel more positive about a stock when an insider has bought shares at above current prices, because that suggests they viewed the stock as good value, even at a higher price. The only individual insider to buy over the last year was Jerry Bauer.
Jerry Bauer purchased 30.00k shares over the year. The average price per share was US$13.86. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
View our latest analysis for Marten Transport
Marten Transport is not the only stock that insiders are buying. For those who like to find small cap companies at attractive valuations, this free list of growing companies with recent insider purchasing, could be just the ticket.
Many investors like to check how much of a company is owned by insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Marten Transport insiders own about US$307m worth of shares (which is 29% of the company). Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.
It's certainly positive to see the recent insider purchase. We also take confidence from the longer term picture of insider transactions. Once you factor in the high insider ownership, it certainly seems like insiders are positive about Marten Transport. Nice! While it's good to be aware of what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. To that end, you should learn about the 3 warning signs we've spotted with Marten Transport (including 1 which shouldn't be ignored).
But note: Marten Transport may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Associated Press

8 minutes ago

• Associated Press

Lexaria Reaches Patent Milestone - 50 Patents Now Granted Worldwide

New patents received for the treatment of epilepsy and for the sublingual delivery of nicotine KELOWNA, BC / ACCESS Newswire / June 23, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the 'Company' or 'Lexaria'), a global innovator in drug delivery platforms, is pleased to announce that it has received 2 new international patents. This now brings Lexaria's total worldwide patent portfolio to 50. 'We are pleased to announce the addition of these patents as we continue to execute on our strategy to broaden Lexaria's patent portfolio. We believe that this not only increases our likelihood of entering into commercial deals within the pharmaceutical industry, but that it also serves as an important building block for establishing and protecting long-term value for our shareholders and all stakeholders,' said Rich Christopher, CEO of Lexaria. 'The achievement of 50 worldwide patents marks the accomplishment of a milestone that had been envisioned by the Company's management for over a decade.' Lexaria has been granted a new patent in Australia within its patent family #24, Compositions and Methods for Treating Epilepsy. This broadens Lexaria's intellectual property protection for the use of its DehydraTECH™ enhanced processing technology related to the treatment of epilepsy outside of the USA, where a strong patent portfolio of 6 existing patents has already been built. This new patent will expire in 2044. Lexaria has also been granted a new patent in Japan within its patent family #20, Compositions and Methods for Sublingual Delivery of Nicotine. This patent joins already-existing patents within the same family in both the USA and Canada. This new patent will expire in 2043. The epilepsy drug market was US$9.5 billion in 2023 and is expected to reach sales of over $15 billion by 2032. Approximately 50 million people in the US alone are affected by epilepsy. The global retail oral nicotine market was valued at US$5.5 billion in 2023 and is expected to grow at 26%/yr until at least 2030, with additional revenue generated within the medically-prescribed market. The nicotine pouch market alone - where DehydraTECH™ has demonstrated absorption benefits in earlier studies - is expected to reach US$25.4 billion in revenue by 2030. Altria Ventures Inc. the 16.67% shareholder of Lexaria Nicotine LLC, holds a non-exclusive license to the use of DehydraTECH with nicotine products. About Lexaria Bioscience Corp. & DehydraTECH DehydraTECH™ is Lexaria's patented drug delivery formulation and processing platform technology which improves the way active pharmaceutical ingredients enter the bloodstream through oral delivery. Lexaria has developed and investigated DehydraTECH with a variety of beneficial molecules in oral formats. DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption and has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 50 patents granted and additional patents pending worldwide. For more information, please visit CAUTION REGARDING FORWARD-LOOKING STATEMENTS This press release includes forward-looking statements. Statements as such term is defined under applicable securities laws. These statements may be identified by words such as 'anticipate,' 'if,' 'believe,' 'plan,' 'estimate,' 'expect,' 'intend,' 'may,' 'could,' 'should,' 'will,' and other similar expressions. Such forward-looking statements in this press release include, but are not limited to, statements by the company relating the Company's ability to carry out research initiatives, receive regulatory approvals or grants or experience positive effects or results from any research or study. Such forward-looking statements are estimates reflecting the Company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that the Company will actually achieve the plans, intentions, or expectations disclosed in these forward-looking statements. As such, you should not place undue reliance on these forward-looking statements. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation and regulatory approvals, managing and maintaining growth, the effect of adverse publicity, litigation, competition, scientific discovery, the patent application and approval process, potential adverse effects arising from the testing or use of products utilizing the DehydraTECH technology, the Company's ability to maintain existing collaborations and realize the benefits thereof, delays or cancellations of planned R&D that could occur related to pandemics or for other reasons, and other factors which may be identified from time to time in the Company's public announcements and periodic filings with the US Securities and Exchange Commission on EDGAR. The Company provides links to third-party websites only as a courtesy to readers and disclaims any responsibility for the thoroughness, accuracy or timeliness of information at third-party websites. There is no assurance that any of Lexaria's postulated uses, benefits, or advantages for the patented and patent-pending technology will in fact be realized in any manner or in any part. No statement herein has been evaluated by the Food and Drug Administration (FDA). Lexaria-associated products are not intended to diagnose, treat, cure or prevent any disease. Any forward-looking statements contained in this release speak only as of the date hereof, and the Company expressly disclaims any obligation to update any forward-looking statements or links to third-party websites contained herein, whether as a result of any new information, future events, changed circumstances or otherwise, except as otherwise required by law. INVESTOR CONTACT: George Jurcic - Head of Investor Relations [email protected] Phone: 250-765-6424, ext 202 SOURCE: Lexaria Bioscience Corp. press release

Yahoo

23 minutes ago

• Yahoo

Africa Animal Feed Grade Calcium Phosphate - CAS 7757-53-9 Market to Worth Over US$ 372.67 Million By 2033

Africa animal feed grade calcium phosphate - CAS 7757-53-9 market is poised for growth, driven by regulatory advancements, sustainable practices, increasing livestock populations, and expanding feed mill capacities, fostering innovation and regional supply chain improvements. Chicago, June 23, 2025 (GLOBE NEWSWIRE) -- The Africa animal feed grade calcium phosphate - CAS 7757-53-9 market is projected to hit the market valuation of US$ 372.67 million by 2033 from US$ 234.84 million in 2024 at a CAGR of 5.35% during the forecast period 2025–2033. During 2023–2024, ministries of agriculture in Egypt, Kenya, South Africa and Nigeria tightened micronutrient labelling rules for compound feed, directly affecting the Africa animal feed grade calcium phosphate - CAS 7757-53-9 market. Egypt's Decree 134/2023 raised minimum available phosphorus from 17 g/kg to 18 g/kg and mandated cadmium below 5 mg/kg. The Nigerian National Agency for Food and Drug Administration and Control now demands traceability that links phosphate consignments back to specific mines. These stricter standards discourage low-purity imports and stimulate procurement from Moroccan, Tunisian and Senegalese processors with ISO 22000 certification. Consequently, distributors in Mombasa and Durban are revising protocols and installing X-ray fluorescence scanners at port warehouses. Download Sample Pages: The same regulatory momentum is harmonizing test methods under the African Organization for Standardization, which circulated draft ARS 1783 in February 2024. Stakeholders expect adoption within 18 months, after which inter-country consignments will require only one certificate of analysis. This simplification is already spurring pre-orders, giving the Africa animal feed grade calcium phosphate - CAS 7757-53-9 market clearer forward visibility. Veterinarians advising large poultry firms in Gauteng report a 12-day cut in compliance turnaround thanks to digitized permits, speeding bulk contracts for loads above 3,000 tons. Such developments show how governance, rather than price, now shapes supplier preference within the Africa market. Africa animal feed grade calcium phosphate - CAS 7757-53-9 market Market Forecast (2033) US$ 372.67 million CAGR 5.35 % By Purity Type Medium-Purity Animal Feed Grade Calcium Phosphate (95-98%) (37.13%) By Product Type Mono-Calcium Phosphate (MCP) (39.26%) By Production Method Wet-Process Phosphoric Acid (50.63%) By Form Granule (63.79%) By Application Poultry Feed (31.07%) By Distribution Channel Offline (65.31%) Top Drivers Rising livestock production boosts demand for nutritional additives. Government support for agriculture increases feed additive adoption. Growing poultry sector in Nigeria drives market expansion. Top Trends Shift towards high-purity calcium phosphate for premium feed. Increased focus on sustainable production in South Africa. Customized feed solutions gaining traction across African farms. Top Challenges High import costs limit access for small-scale farmers. Inconsistent supply chains disrupt market in rural Africa. Lack of awareness hinders adoption in underdeveloped regions. Phosphate Rock Supply Chains and Processing Capacities Driving Cost Realities North Africa remains the backbone source of feed-grade phosphates for sub-Saharan formulators, with Morocco's OCP extracting 32 million tons of phosphate rock in 2023 from the Khouribga, Benguerir and Youssoufia complexes. Out of this stream, 1.4 million tons were upgraded into animal-feed monocalcium and dicalcium lines at Jorf Lasfar and Safi, then shipped through bagging terminals with anti-caking additives. Tunisia's Gafsa basin, recovering from strike disruptions, restored output to three million tons, allowing producer Groupe Chimique Tunisien to reopen line 2 of its Sfax feed-grade plant in March 2024. Senegal's ICS added a twin rotary kiln enabling 180,000-ton dicalcium throughput, aimed primarily at Ghanaian and Ivorian feed mills. Despite rising volumes, freight bottlenecks remain the pivotal cost driver. Cape-Sized rates from Jorf Lasfar to Mombasa hit US$ 42 per ton in January 2024 after Red Sea re-routing, then slipped to US$ 29 by May. Producers responded by extending CIF contracts to Dar es Salaam distributors, cushioning formulators and stabilizing the Africa animal feed grade calcium phosphate - CAS 7757-53-9 market. A micronizing corridor near Richards Bay now toll-grinds Tunisian granules to 425-micron powder, trimming factory energy bills by eight kWh per ton. As more grinding hubs open, logistics savings should preserve the Africa animal feed grade calcium phosphate - CAS 7757-53-9 market's cost edge over South American alternatives. Livestock Population Shifts Elevating Demand For Bone Strengthening Minerals FAO's 2024 update shows Africa raising 1.28 billion chickens, 350 million goats, 200 million cattle and 35 million dairy cows, a scale that keeps mineral nutrition firmly on procurement agendas. Modern genetics magnify the trend: trials at South Africa's Arcadia center reveal today's Cobb broilers consuming 1.7 grams more available phosphorus per kilogram of live weight than 2019 lines, requiring an extra 0.4 kg of dicalcium phosphate per metric ton of feed. Nigerian formulators in Ogun State corroborate the shift, now employing in-feed optical sensors to meter calcium phosphate precisely and avoid growth dips during hot-weather feeding windows. Urbanization has spurred dairy clusters around Cairo, Addis Ababa and Nairobi, where cows yield 6,500 liters annually on total-mixed rations. A 2023 survey by the Ethiopian Meat and Dairy Industry Institute logged 14 grams of supplemental calcium phosphate per cow per day in these systems. Such evidence shows that the Africa animal feed grade calcium phosphate - CAS 7757-53-9 market increasingly mirrors stocking-density hotspots. Feed plants in Kiambu now draw 900 tons monthly after farms installed automated calf stations in November 2023, while early orders linked to a 60,000-head Brahman feedlot program in northern Côte d'Ivoire are already visible on Dakar export dashboards, reinforcing upside for the Africa animal feed grade calcium phosphate - CAS 7757-53-9 market. Regional Feed Mill Investments Transforming Localized Formulation and Distribution Patterns Since 2022, fourteen greenfield feed mills have come online across East and West Africa, adding 2.1 million tons of pelleting capacity. Highlights include Biyinzika Pro's 240,000-ton unit in Buikwe, Uganda, and Flour Mills of Ghana's mega-plant at Tema harbour, which unloads 30-ton calcium-phosphate silos directly from pneumatic trucks. These facilities shift procurement inland: before commissioning, Ugandan integrators trucked nine-hundred-kilogram bags of dicalcium from Mombasa; they now book bulk tankers via the Mukuru barge terminal, shaving four days from turnaround. Automation tightens inclusion accuracy, with Tema's loss-in-weight feeders dosing calcium phosphate to 10-gram resolution in line with September 2023 breeder standards. The investment wave directly reshapes the Africa animal feed grade calcium phosphate - CAS 7757-53-9 market. Because new mills sit close to grain baskets, inbound phosphate moves shorter distances, reducing bag breakage and encouraging a switch to micro-granules over fine powder. Moroccan supplier Phosfeed logged a ten-fold rise in 1.4-millimetre granule orders from Kenya between October 2023 and April 2024, after the Naivasha mill retrofitted its bins with low-angle agitators. Transport firms add that the coarser grade flows smoothly through 20-foot flexi-bags, enabling sunflower-cake backhauls and lifting average truck loads to 46 tons. As more producers replicate the setup, supply chains will tighten further, underpinning reliability in the Africa animal feed grade calcium phosphate - CAS 7757-53-9 market. Competition Dynamics Between Dicalcium and Monocalcium Phosphate Suppliers Intensify Monocalcium phosphate (MCP) has long dominated layer and aquaculture diets in China and Europe, yet in Africa dicalcium phosphate (DCP) still accounts for roughly four out of five consignments. The technical gap, however, is closing. Field data from the Rwanda Tilapia Research Station published January 2024 show MCP delivering a 30-gram higher final weight in 18-week grow-outs, an advantage valued at US$ 18 per ton of feed. As a result, Ugandan fish-feed maker NaFICO switched three of its five lines to MCP in March, placing a 6,600-ton annual contract with Yunnan Phosphate Haikou's Durban hub. South African integrator Astral also initiated MCP trials across its parent-stock barns in April. This shift is redefining the Africa animal feed grade calcium phosphate - CAS 7757-53-9 market. MCP lands in Lagos at US$ 610 per ton, roughly US$ 45 dearer than DCP, yet provides 6.5 grams of available phosphorus in a 30-gram dose against DCP's 5.4. Broiler formulation trials show the premium offset within eight days of grow-out thanks to better feed conversion. Moroccan exporter Europhos has responded with a 'Di-Mono Flex' grade blending MCP and DCP in a three-to-two ratio for stepwise adoption. Cameroun's Somdiaa mill booked 2,400 tons of the blend for Q2 2024, demonstrating how competitive innovation is reshaping the Africa animal feed grade calcium phosphate - CAS 7757-53-9 market. Price Trend Analysis: Freight, Energy And Currency Variables Determine Margins Feed-grade DCP prices in Africa have swung sharply since mid-2023, driven more by energy and currency moves than raw phosphate. In September 2023 Moroccan DCP landed in Abidjan at US$ 530 per ton when Brent crude sat near US$ 92, inflating sulphuric-acid costs. By February 2024 the same cargo fetched US$ 480 as oil softened and Senegal ended a power-rationing mandate, restoring kiln output. Currency shifts complicate matters: the naira's fall from 762 to 1,300 per US dollar between June 2023 and January 2024 forced Lagos distributors to shorten quotation validity from 90 to 21 days. These swings shape trading strategies inside the Africa animal feed grade calcium phosphate - CAS 7757-53-9 market. East African integrators now hedge diesel by buying DCP on a delivered-factory basis that locks freight surcharges for 60 days. Several distributors index invoices to shillings, rand and euros, avoiding single-currency shocks. Forwarders note that every US$ 10 move in bunker fuel lifts the landed price of Moroccan DCP in Mombasa by US$ 2.4 per ton, or 0.6 US cents per kilogram of finished broiler feed. With Suez convoys flowing again, analysts anticipate a stable pricing channel through late 2024, granting the Africa animal feed grade calcium phosphate - CAS 7757-53-9 market its first period of predictable costs since 2021. Request Report Customization: Strategic Opportunities For New Entrants And Existing Players Through 2028 Regulatory convergence, infrastructure upgrades and heavier animal weights are opening the door to fresh suppliers. AgBioTrack projects that by 2026 six new blending or repacking hubs will be required in Nigeria, Kenya and Tanzania to match feed-mill growth. Chinese producer Chongqing Sansheng is scouting a 20,000-ton bagging site in Port Harcourt to cut lead times from ten weeks to three, while Turkey's Toros Tarim inked a February 2024 deal with the Port of Beira for a 40,000-ton terminal that will break-bulk Moroccan MCP for Malawi and Zambia, trimming north-south haulage by 200 kilometers. Such moves position the Africa animal feed grade calcium phosphate - CAS 7757-53-9 market for sharper competition, yet service quality remains decisive. Integrated poultry groups now demand vendor-managed inventory with 21-day visibility, and suppliers offering live dashboards secure repeat orders. Phosfeed's VMI pilot at Rwanda's Uzima Farms eliminated emergency haulage in six months. Technical support is another lever: OCP's mobile lab analyzed 1,800 feed samples across eleven countries in 2023, helping mills refine calcium-to-phosphorus ratios. Sustainability will also count; players documenting cradle-to-farm carbon footprints are likely to gain preferred status when major retailers introduce stricter sourcing charters in 2025, bolstering prospects across the Africa animal feed grade calcium phosphate - CAS 7757-53-9 market. Africa Anima Feed Grade Calcium Phosphate -CAS 7757-53-9 Market Key Players: Phosphea (Groupe Roullier) OCP Group Yara International Hubei Xingfa Chemicals Group Co., LTD Phosagro Nutrien Ltd. Polifar Group Limited The Mosaic Company Ecophos (Prayon Group) Other Prominent Players Key Market Segmentation: By Purity Type High-Purity Animal Feed Grade Calcium Phosphate (≥98%) Medium-Purity Animal Feed Grade Calcium Phosphate (95-98%) Low-Purity Animal Feed Grade Calcium Phosphate (<95%) By Product Type Mono-Calcium Phosphate (MCP) Di-Calcium Phosphate (CP) MCP (Mixed CP/MCP) Tri-Calcium Phosphate (TCP) Others By Production Method Wet-Process Phosphoric Acid Hydrochloric Acid Process Defluorinated Phosphate (Thermal Process) By Form Powder Granules By Application Poultry Feed Cattle Feed Ruminant Feed (Cattle, Sheep) Swine Feed Aquaculture Feed Others By Distribution Channel Online Offline Direct Distributors Retail Feed Stores Others (Importers & Traders) By Country Africa South Africa Namibia Botswana Zimbabwe Mozambique Zambia Rest of Africa Need More Info? Ask Before You Buy: About Astute Analytica Astute Analytica is a global market research and advisory firm providing data-driven insights across industries such as technology, healthcare, chemicals, semiconductors, FMCG, and more. We publish multiple reports daily, equipping businesses with the intelligence they need to navigate market trends, emerging opportunities, competitive landscapes, and technological advancements. With a team of experienced business analysts, economists, and industry experts, we deliver accurate, in-depth, and actionable research tailored to meet the strategic needs of our clients. At Astute Analytica, our clients come first, and we are committed to delivering cost-effective, high-value research solutions that drive success in an evolving marketplace. Contact Us:Astute AnalyticaPhone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World)For Sales Enquiries: sales@ Follow us on: LinkedIn | Twitter | YouTube CONTACT: Contact Us: Astute Analytica Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World) For Sales Enquiries: sales@ Website: in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Yahoo

27 minutes ago

• Yahoo

51Talk Online Education Group to Present at the Small Cap Growth Virtual Investor Conference June 26th, 2025

Company invites individual and institutional investors, as well as advisors and analysts, to attend online at SINGAPORE, June 23, 2025 (GLOBE NEWSWIRE) -- 51Talk Online Education Group (NYSE American: COE), based in Singapore, focused on global online education, today announced that David Chung, the Company's investor relations vice president, will present live at the Small Cap Growth Virtual Investor Conference hosted by on June 26th, 2025. DATE: June 26th, 2025TIME: 9:30 a.m. EDTLINK: REGISTER HERE Available for 1x1 meetings: June 26th, 2025 This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event. It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates. Learn more about the event at Recent Company Highlights Gross billings for the first quarter of 2025 were US$21.9 million, a 74.6% growth from the first quarter of 2024. Net revenues were US$18.2 million for the first quarter of 2025, a 93.1% increase from US$9.4 million for the first quarter of 2024. The number of active students with attended lesson consumption was approximately 81,100 in the first quarter of 2025, representing a 75.5% increase from approximately 46,200 for the first quarter of 2024. About 51Talk Online Education Group 51Talk Online Education Group (NYSE American: COE) is a global online education platform with core expertise in English education. The Company's mission is to make quality education accessible and affordable. The Company's online and mobile education platforms enable students to take live interactive English lessons, on demand. The Company connects its students with a large pool of highly qualified teachers that it assembled using a shared economy approach, and employs student and teacher feedback and data analytics to deliver a personalized learning experience to its students. About Virtual Investor Conferences®Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors. Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors. CONTACTS:51Talk Online Education GroupDavid ChungInvestor Relations Vice President davidchung@ WangInvestor Relations Managerwangjinling@ Virtual Investor Conferences John M. ViglottiSVP Corporate Services, Investor AccessOTC Markets Group (212) 220-2221johnv@ in to access your portfolio